These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
559 related articles for article (PubMed ID: 15844188)
1. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma. Patel BP; Shah PM; Rawal UM; Desai AA; Shah SV; Rawal RM; Patel PS J Surg Oncol; 2005 May; 90(2):81-8. PubMed ID: 15844188 [TBL] [Abstract][Full Text] [Related]
2. Clinical significance of MMP-2 and MMP-9 in patients with oral cancer. Patel BP; Shah SV; Shukla SN; Shah PM; Patel PS Head Neck; 2007 Jun; 29(6):564-72. PubMed ID: 17252594 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer. Shah FD; Shukla SN; Shah PM; Shukla HK; Patel PS Indian J Cancer; 2009; 46(3):194-202. PubMed ID: 19574670 [TBL] [Abstract][Full Text] [Related]
4. Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases. Xie M; Sun Y; Li Y Laryngoscope; 2004 Dec; 114(12):2243-8. PubMed ID: 15564854 [TBL] [Abstract][Full Text] [Related]
5. Expression and clinical significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral squamous cell carcinoma. de Vicente JC; Fresno MF; Villalain L; Vega JA; Hernández Vallejo G Oral Oncol; 2005 Mar; 41(3):283-93. PubMed ID: 15743691 [TBL] [Abstract][Full Text] [Related]
6. Increased expression and activation of matrix metalloproteinase-2 (MMP-2) in O-1N: hamster oral squamous cell carcinoma with high potential lymph node metastasis. Zhang Y; Wang C; Mizukami H; Itoh H; Kusama M; Ozawa K; Jinbu Y J Exp Clin Cancer Res; 2006 Sep; 25(3):417-23. PubMed ID: 17167983 [TBL] [Abstract][Full Text] [Related]
7. Active-MMP2 in cancer cell nests of oral cancer patients: correlation with lymph node metastasis. Kawamata H; Uchida D; Hamano H; Kimura-Yanagawa T; Nakashiro KI; Hino S; Omotehara F; Yoshida H; Sato M Int J Oncol; 1998 Oct; 13(4):699-704. PubMed ID: 9735398 [TBL] [Abstract][Full Text] [Related]
8. [The effects of MMPs and TIMPs on the metastasis of oral squamous cell carcinoma to neck lymph nodes]. Liu G; Li J; Li Z; Chen X Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Aug; 19(4):216-8, 224. PubMed ID: 12539723 [TBL] [Abstract][Full Text] [Related]
9. Characterization of 3 oral squamous cell carcinoma cell lines with different invasion and/or metastatic potentials. Erdem NF; Carlson ER; Gerard DA; Ichiki AT J Oral Maxillofac Surg; 2007 Sep; 65(9):1725-33. PubMed ID: 17719389 [TBL] [Abstract][Full Text] [Related]
10. Predictive value of laminin-5 and membrane type 1-matrix metalloproteinase expression for cervical lymph node metastasis in T1 and T2 squamous cell carcinomas of the tongue and floor of the mouth. Kawano K; Yanagisawa S Head Neck; 2006 Jun; 28(6):525-33. PubMed ID: 16619276 [TBL] [Abstract][Full Text] [Related]
11. Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis. de Vicente JC; Lequerica-Fernández P; Santamaría J; Fresno MF J Oral Pathol Med; 2007 Aug; 36(7):415-24. PubMed ID: 17617835 [TBL] [Abstract][Full Text] [Related]
12. The matrix metalloproteinase system in oral squamous cell carcinoma. Baker EA; Leaper DJ; Hayter JP; Dickenson AJ Br J Oral Maxillofac Surg; 2006 Dec; 44(6):482-6. PubMed ID: 16338034 [TBL] [Abstract][Full Text] [Related]
13. [The correlation between neck lymphy node metastasis and matrixmetalloproteinase-2 expression at the invasive tumor front of oral squamous cell carcinomas]. Liu LK; Li YN; Jiang HB; He ZX; Yi XZ Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Apr; 22(2):106-8. PubMed ID: 15190788 [TBL] [Abstract][Full Text] [Related]
14. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma. Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466 [TBL] [Abstract][Full Text] [Related]
15. Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients. González-García R; Naval-Gías L; Rodríguez-Campo FJ; Sastre-Pérez J; Muñoz-Guerra MF; Gil-Díez Usandizaga JL J Oral Maxillofac Surg; 2008 Jul; 66(7):1390-8. PubMed ID: 18571022 [TBL] [Abstract][Full Text] [Related]
16. Predictive value of lymph node and tumor matrix metalloproteinase expression in the analysis of metastatic periampullary tumors. McKenna GJ; Meneghetti A; Chen YL; Mui AL; Ong C; Scudamore CH; McMaster WR; Owen DA; Chung SW J Surg Oncol; 2005 Jun; 90(4):239-46. PubMed ID: 15906368 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer. Jordan RC; Macabeo-Ong M; Shiboski CH; Dekker N; Ginzinger DG; Wong DT; Schmidt BL Clin Cancer Res; 2004 Oct; 10(19):6460-5. PubMed ID: 15475433 [TBL] [Abstract][Full Text] [Related]
18. Prospective validation of the Martinez-Gimeno clinicopathologic scoring system (MGSS) for evaluating risk of cervical lymph node metastases of squamous cell carcinoma of the oral cavity. Martínez-Gimeno C; Molinero AP; Castro V; Sastre MJ; Castro EE; Aguirre-Jaime A Head Neck; 2005 Apr; 27(4):320-5. PubMed ID: 15700293 [TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139 [TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinase 2 and its tissue inhibitor in oral squamous cell carcinoma. Gao ZB; Duan YQ; Zhang L; Chen DW; Ding PT Int J Mol Med; 2005 Oct; 16(4):599-603. PubMed ID: 16142392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]